Published positive Phase 2 trial results of onvansertib in combination with FOLFIRI and bev in second-line KRAS mutant mCRC in the ...

The School of Neurobiology, Biochemistry & Biophysics, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel ...

This valuable study uses robust time-dependent microscopy assays to show that during HIV-1 infection, the viral accessory protein Vif causes cell cycle arrest during metaphase and not G2/M as ...

For the past decade, scientists have relied almost exclusively on CRISPR-Cas systems for genome editing. Now, a smaller but equally efficient nuclease is here to compete.

2024 – Novartis today presented 12-month data from the Phase III APPEAR-C3G study at American Society of Nephrology (ASN) Kidney Week 2024 showing that patients with C3 glomerulopathy (C3G) treated ...

in participants with selected CD19+ and CD20+ relapsed/refractory B-cell NHL. The phase 1, open label clinical study is designed to enroll up to 10 participants and is being conducted in ...

Agatha All Along is currently streaming, and that means that we're almost done with Marvel Phase 5, but there's still a way to wait yet until Marvel Phase 6 kicks off properly. That's not to say ...

If you’re looking for a great senior cell phone plan from one of the nation’s most trusted mobile carriers, there are plenty of options. If you want a plan for yourself and a spouse or another family ...

"Instead of looking at AD just through the usual lens of plaques and tangles, we focused on how specific cell types were changed in each phase," study author Dr. Kyle Travaglini, Ph.D., a ...

Advent Technologies has said that its second-generation fuel cell membrane electrode assembly (MEA ... The US-headquartered firm, with operations in Greece, said that its Advent MEA G2 technology, ...